Simon Baker analyst REDBURN

Currently out of the existing stock ratings of Simon Baker, 3 are a BUY (18.75%), 7 are a HOLD (43.75%), 6 are a SELL (37.5%).

Simon Baker

Work Performance Price Targets & Ratings Chart

Analyst Simon Baker, currently employed at REDBURN, has had 62.5% of price targets met with an average potential upside of 14.78%, reached in 388 days on average. Previously, Simon Baker worked at TD COWEN, SOCGEN.

Simon Baker has documented 30 price targets and ratings displayed on 8 stocks. The coverage is on Healthcare, Communication Services sectors.

Most recent stock forecast was given on MRNA, Moderna at 03-Sep-2026.

Wall Street Analyst Simon Baker

Analyst best performing recommendations are on MRNA (MODERNA).
The best stock recommendation documented was for MRNA (MODERNA) on 2/1/2022. The price target of $165 was fulfilled within 2 days with a profit of $7.74 (4.48%), with a performance score of 22.4.

Average potential price target upside

BNTX BioNTech SE HOLX Hologic META Meta Platforms PSO Pearson PLC ADR WPP WPP PLC ADR NVO Novo Nordisk A/S FOXA Fox Corp MRNA Moderna

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Nov-2021

$110

$24.4 (28.50%)

$130

8 days ago
(09-Nov-2026)

16/47 (34.04%)

$22.49 (25.70%)

71

Buy Since 11-Dec-2024

$125

$39.4 (46.03%)

$140

13 days ago
(04-Nov-2026)

0/5 (0%)

$38.08 (43.81%)

Buy Since 04-Aug-2025

$110

$24.4 (28.50%)

$130

13 days ago
(04-Nov-2026)

4/8 (50%)

$23.08 (26.55%)

23

Buy Since 11-Mar-2025

$106

$20.4 (23.83%)

$114

13 days ago
(04-Nov-2026)

3/14 (21.43%)

$19.08 (21.95%)

46

Buy Since 14-Nov-2024

$132

$46.4 (54.21%)

$136

1 months 3 days ago
(14-Oct-2026)

0/7 (0%)

$43.34 (48.88%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Simon Baker most bullish on?

Potential upside of $-142.37 has been obtained for MRNA (MODERNA)

What Year was the first public recommendation made by Simon Baker?

On 2017
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?